| HCCR-2 probably represents a new oncogene that is related to tumorigenesis, functioning as a negative regulator of the p53 tumor suppressor | liver, |
| Identification and differential expression of novel human cervical cancer oncogene HCCR-2 in human cancers and its involvement in p53 stabilization. | liver,cervical, |
| Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR-2 transgenic mice. | liver,breast, |
| The HCCR oncoprotein as a biomarker for human breast cancer. | liver,breast, |
| The phosphatidylinositol 3-kinase/Akt pathway regulates the HCCR-1 oncogene expression. | liver, |
| These results suggest that the HCCR-1 oncogene expression was regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway. | liver, |
| HCCR-1, a novel oncogene, encodes a mitochondrial outer membrane protein and suppresses the UVC-induced apoptosis. | liver, |
| TCF and beta-catenin binding plays important roles in HCCR-1 oncogene expression. | liver, |
| TCF/beta-catenin plays an important role in HCCR-1 oncogene expression. | liver, |
| Dual action of apolipoprotein E-interacting HCCR-1 oncoprotein and its implication for breast cancer and obesity. | liver,breast, |
| Transdifferentiation-inducing HCCR-1 oncogene. | liver, |
| Clinical implication of elevated human cervical cancer oncogene-1 expression in esophageal squamous cell carcinoma. | esophageal,cervical, |
| Quantitative detection of the human cervical cancer oncogene for monitoring the minimal residual disease in acute leukemia. | leukemia,cervical, |
| Data show that the activation of STAT3 protein upregulated human cervical cancer oncogene (HCCR) expression in gastric cancer cells. | gastric,liver,cervical, |